Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug resistance in Cryptococcus neoformans.

John R. Perfect1, Gary M. Cox

  • 1Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, USA

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fungal Infections of the Bones and Joints.

Current infectious disease reportsยท2001
See all related articles

Antifungal drug resistance in Cryptococcus neoformans is a growing problem, leading to treatment failures. This review explores resistance mechanisms and strategies to overcome them, including new therapies and optimized drug delivery.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cryptococcus neoformans is a significant global opportunistic fungal pathogen.
  • Established treatments include amphotericin B, flucytosine, and azoles.
  • Treatment failures are increasingly reported due to factors like antifungal drug resistance.

Purpose of the Study:

  • To review the issues and mechanisms of antifungal drug resistance in Cryptococcus neoformans.
  • To identify strategies for preventing and treating antifungal drug resistance.

Main Methods:

  • Literature review of antifungal drug resistance in Cryptococcus neoformans.
  • Analysis of current and emerging treatment approaches.

Main Results:

Related Experiment Videos

  • Direct antifungal drug resistance is a key factor in treatment failures.
  • Various mechanisms contribute to the development of resistance.
  • Multiple strategies can be employed to combat resistance.

Conclusions:

  • Addressing antifungal drug resistance in Cryptococcus neoformans is crucial for effective patient outcomes.
  • A multifaceted approach combining immune modulation, optimized dosing, novel drug delivery, and new antifungal agents is necessary.
  • Further research and development of new antifungal therapies are essential.